OVERVIEW

Cancer Summaries and Commentaries™: Report From Orlando on Advancements in Multiple Myeloma is organized by Physicians' Education Resource, LLC (PER).

Release Date: December 24, 2019
Expiration Date: December 24, 2020

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
This online continuing medical education (CME) activity is designed to update physicians on data presented at the American Society of Hematology Annual Meeting, held in December 2019 in Orlando, Florida. Cancer Summaries and Commentaries™: Report From Orlando on Advancements in Multiple Myeloma facilitates the critical assessment and clinical integration of new evidence, when appropriate. The activity reviews 8 of the most clinically pertinent multiple myeloma (MM) presentations from the meeting. For each abstract, a text-based summary of the background, study design, key clinical data, and study conclusions is accompanied by expert perspectives that provide insight into how clinicians can apply these findings to their clinical practice to improve patient care.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Outline novel treatment options exploring targeted therapies, immunotherapies, and combination strategies among patients with multiple myeloma
• Explain the study design, rationale, and results of recent clinical trials evaluating novel strategies for the treatment of multiple myeloma
• Consider best practices to apply novel treatment strategies for the management of patients with multiple